MELTF gene

Known as: MFI2, p97 MELANOMA ANTIGEN, MELTF 
 

Topic mentions per year

Topic mentions per year

1989-2018
02419892018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Iron is an essential element in many biological processes. In vertebrates, serum transferrin is the major supplier of iron to… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2007
2007
Adenovirus serotype 5 (Ad5) is widely used in the development of gene therapy protocols. However, current gene therapy strategies… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 5
Is this relevant?
2006
2006
Melanotransferrin (MTf) or tumor antigen p97 is a transferrin homolog that binds one iron (Fe) atom and has been suggested to… (More)
  • figure 1
  • table 1
Is this relevant?
2002
2002
The blood-brain barrier (BBB) performs a neuroprotective function by tightly controlling access to the brain; consequently it… (More)
Is this relevant?
1996
1996
Several investigations have implicated the involvement of metals in neuropathologies. In particular, the disruption of iron… (More)
Is this relevant?
1996
1996
The EOS47 antigen is a 100-kD cell surface glycoprotein selectively expressed by avian retrovirus-transformed eosinophils and… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
1996
1996
One method of iron transport across the blood brain barrier (BBB) involves the transferrin receptor (TR), which is localized to… (More)
Is this relevant?
1992
1992
The iron-binding properties of melanotransferrin, the tumour-associated antigen also known as p97, have been investigated by UV… (More)
Is this relevant?
1991
1991
The human melanoma cell line, SK-MEL-28, expresses high levels of melanotransferrin. The uptake of inorganic iron (Fe) complexes… (More)
Is this relevant?
1991
1991
The role of the transferrin homologue, melanotransferrin (p97), in iron metabolism has been studied using the human melanoma cell… (More)
Is this relevant?